Core Viewpoint - The company, Boji Pharmaceutical, has received a patent from the National Intellectual Property Administration for a method to measure gallic acid in berberine [2] Group 1 - The patent is titled "A method for determining gallic acid in berberine" [2] - The announcement was made on the evening of September 19 [2]

Core Viewpoint - The company Boji Pharmaceutical Technology Co., Ltd. has received a new invention patent from the National Intellectual Property Administration, which enhances the detection method of gallic acid in berberine, contributing to the pharmaceutical ingredient testing field [1]. Group 1 - The patent is titled "A Method for Determining Gallic Acid in Berberine" [1] - The invention provides a method that achieves good separation of tannic acid, berberine, and gallic acid, with short detection time and high separation efficiency [1] - This method lays a solid foundation for controlling the safety and stability of berberine [1]

Group 1 - Company obtained an invention patent certificate from the National Intellectual Property Administration for a method to measure gallic acid in berberine [1] - As of the report date, the market capitalization of the company is 4 billion yuan [3] Group 2 - For the first half of 2025, the company's revenue composition shows that the service industry accounts for 99.46%, while other businesses account for 0.54% [2]

南财智讯9月19日电，博济医药发布公告称，公司近日收到国家知识产权局颁发的1项《发明专利证 书》。专利名称为"一种测定鞣酸小檗碱中没食子酸的方法"。 ...

近日，博济医药科技股份有限公司获国家知识产权局颁发的一项发明专利证书。专利名称为"一种测定 鞣酸小檗碱中没食子酸的方法"，证书号第8272934号，专利号ZL202510318197.1，申请日为2025年3月 18日，授权公告日为2025年9月19日。该方法涉及药品成分检测领域，能实现鞣酸、小檗碱和没食子酸 良好分离，检测时间短、分离度高。此专利虽对公司经营业绩无重大影响，但利于公司技术创新，完善 知识产权保护体系，提升核心竞争力。 ...